UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC‐ENHANCE

Transfusion (Philadelphia, Pa.), 2024-02, Vol.64 (2), p.223-235

2024

Volltextzugriff (PDF)

Patient‐related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS‐CAN prospective study

British journal of haematology, 2016-07, Vol.174 (1), p.88-101

2016

Volltextzugriff (PDF)

Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies

American journal of hematology, 2024-03, Vol.99 (3), p.473-476

2024

Volltextzugriff (PDF)

Impact of Bone Marrow Fibrosis in MDS Patients Treated with Azacitidine

Blood, 2016-12, Vol.128 (22), p.4339-4339

2016

Volltextzugriff (PDF)

Prophylactic Rh and Kell Antigen Matching Significantly Decreases Rates of Alloimmunization in Transfusion Dependent MDS Patients

Blood, 2014-12, Vol.124 (21), p.4297-4297

2014

Volltextzugriff (PDF)

A predictive model of response to erythropoietin stimulating agents in myelodysplastic syndrome: from the Canadian MDS patient registry

Annals of hematology, 2017-12, Vol.96 (12), p.2025-2029

2017

Volltextzugriff (PDF)

Validation of the Nordic Scoring System for Erythropoietic Stimulating Agents in MDS Using IWG 2006 Erythroid Response Criteria

Blood, 2012-11, Vol.120 (21), p.1721-1721

2012

Volltextzugriff (PDF)

Patient Related Factors Have an Indepedent Impact on Overall Survival in Myelodysplastic Syndrome Patients: A Report of the MDS-Can Registry

Blood, 2014-12, Vol.124 (21), p.165-165

2014

Volltextzugriff (PDF)

Iron Chelation Is Associated with Improved Survival Adjusting for Disease and Patient Related Characteristics in Low/Int-1 Risk MDS at the Time of First Transfusion Dependence: A MDS-CAN Study

Blood, 2015-12, Vol.126 (23), p.1701-1701

2015

Volltextzugriff (PDF)

The Effects of Azacitidine On Quality of Life: A Prospective Longitudinal Assessment

Blood, 2012-11, Vol.120 (21), p.4938-4938

2012

Volltextzugriff (PDF)

The Independent Effects of Frailty and Comorbidity On the Quality of Life in MDS Patients

Blood, 2012-11, Vol.120 (21), p.699-699

2012

Volltextzugriff (PDF)

CLINICAL RESULTS OF LONG TERM FOLLOW-UP OF A LARGE ACTIVE SURVEILLANCE COHORT

The Journal of urology, 2009, Vol.181 (4), p.606-606

2009

Volltextzugriff (PDF)

The Effects of Azacitidine on Quality of Life Measured Longitudinally In MDS Patients Treated at a Tertiary Care Center

Blood, 2010-11, Vol.116 (21), p.2571-2571

2010

Volltextzugriff (PDF)

Transfusion Dependence and Low Hemoglobin Have the Greatest Impact On Quality of Life (QOL) in MDS Patients - a Tertiary Care Cross Sectional and Longitudinal Study

Blood, 2009-11, Vol.114 (22), p.2500-2500

2009

Volltextzugriff (PDF)

Does Prostate Biopsy after HDR Brachytherapy Have Any Clinical Significance?

Brachytherapy, 2013-03, Vol.12, p.S28-S29

2013

Volltextzugriff (PDF)

Does Prostate Biopsy after HDR Brachytherapy Have Any Clinical Significance?

Journal of medical imaging and radiation sciences, 2014-06, Vol.45 (2), p.176-177

2014

Volltextzugriff (PDF)

Mechanisms for Tax Regulation of CO2-Equivalent Emissions

Energies (Basel), 2022-10, Vol.15 (19), p.7111

2022

Volltextzugriff (PDF)

Tailored Blockchain Applications for the Natural Gas Industry: The Case Study of SOCAR

Energies (Basel), 2022-08, Vol.15 (16), p.6010

2022

Volltextzugriff (PDF)

Fuzzy-Logical model for analysis of sustainable development of fuel and energy complex enterprises

AIMS energy, 2023-01, Vol.11 (5), p.974-990

2023

Volltextzugriff (PDF)

Mechanisms for Tax Regulation of CO[sub.2]-Equivalent Emissions

Energies (Basel), 2022-09, Vol.15 (19)

2022

Volltextzugriff (PDF)

Hypofractionated Concomitant Intensity-Modulated Radiotherapy Boost for High-Risk Prostate Cancer: Late Toxicity

International journal of radiation oncology, biology, physics, 2012-02, Vol.82 (2), p.898-905

2012

Volltextzugriff (PDF)

Development of a Single-Replicon miniBYV Vector for Co-expression of Heterologous Proteins

Molecular biotechnology, 2015-02, Vol.57 (2), p.101-110

2015

Volltextzugriff (PDF)

Quality of Life After Hypofractionated Concomitant Intensity-Modulated Radiotherapy Boost for High-Risk Prostate Cancer

International journal of radiation oncology, biology, physics, 2012-06, Vol.83 (2), p.617-623

2012

Volltextzugriff (PDF)

Vitamin D insufficiency is common in patients with nonmetastatic prostate cancer

Nutrition research (New York, N.Y.), 2011, Vol.31 (1), p.21-26

2011

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

Science & Technology
(11)
Humans
(8)
Life Sciences & Biomedicine
(8)
Male
(5)
Prospective Studies
(5)
Aged
(4)
Hematology
(4)
Radiology
(4)
Antigens
(3)
Biological And Medical Sciences
(3)
Energy & Fuels
(3)
Hematology, Oncology And Palliative Medicine
(3)
Medical Sciences
(3)
Myelodysplastic Syndrome
(3)
Myelodysplastic Syndromes
(3)
Nephrology. Urinary Tract Diseases
(3)
Oncology
(3)
Patients
(3)
Prostate
(3)
Quality Of Life
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC‐ENHANCE

Patient‐related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS‐CAN prospective study

Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies

Impact of Bone Marrow Fibrosis in MDS Patients Treated with Azacitidine

Prophylactic Rh and Kell Antigen Matching Significantly Decreases Rates of Alloimmunization in Transfusion Dependent MDS Patients

A predictive model of response to erythropoietin stimulating agents in myelodysplastic syndrome: from the Canadian MDS patient registry

Validation of the Nordic Scoring System for Erythropoietic Stimulating Agents in MDS Using IWG 2006 Erythroid Response Criteria

Patient Related Factors Have an Indepedent Impact on Overall Survival in Myelodysplastic Syndrome Patients: A Report of the MDS-Can Registry

Iron Chelation Is Associated with Improved Survival Adjusting for Disease and Patient Related Characteristics in Low/Int-1 Risk MDS at the Time of First Transfusion Dependence: A MDS-CAN Study

The Effects of Azacitidine On Quality of Life: A Prospective Longitudinal Assessment

The Independent Effects of Frailty and Comorbidity On the Quality of Life in MDS Patients

CLINICAL RESULTS OF LONG TERM FOLLOW-UP OF A LARGE ACTIVE SURVEILLANCE COHORT

The Effects of Azacitidine on Quality of Life Measured Longitudinally In MDS Patients Treated at a Tertiary Care Center

Transfusion Dependence and Low Hemoglobin Have the Greatest Impact On Quality of Life (QOL) in MDS Patients - a Tertiary Care Cross Sectional and Longitudinal Study

Does Prostate Biopsy after HDR Brachytherapy Have Any Clinical Significance?

Does Prostate Biopsy after HDR Brachytherapy Have Any Clinical Significance?

Mechanisms for Tax Regulation of CO2-Equivalent Emissions

Tailored Blockchain Applications for the Natural Gas Industry: The Case Study of SOCAR

Fuzzy-Logical model for analysis of sustainable development of fuel and energy complex enterprises

Mechanisms for Tax Regulation of CO[sub.2]-Equivalent Emissions

Hypofractionated Concomitant Intensity-Modulated Radiotherapy Boost for High-Risk Prostate Cancer: Late Toxicity

Development of a Single-Replicon miniBYV Vector for Co-expression of Heterologous Proteins

Quality of Life After Hypofractionated Concomitant Intensity-Modulated Radiotherapy Boost for High-Risk Prostate Cancer

Vitamin D insufficiency is common in patients with nonmetastatic prostate cancer

Suchergebnisse filtern